| Year |
Citation |
Score |
| 2020 |
Wainger BJ, Macklin EA, Vucic S, McIlduff CE, Paganoni S, Maragakis NJ, Bedlack R, Goyal NA, Rutkove SB, Lange DJ, Rivner MH, Goutman SA, Ladha SS, Mauricio EA, Baloh RH, ... ... Phielipp N, et al. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. Jama Neurology. PMID 33226425 DOI: 10.1001/jamaneurol.2020.4300 |
0.389 |
|
| 2019 |
Paff M, Wang AS, Phielipp N, Vadera S, Morenkova A, Hermanowicz N, Hsu FPK. Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease. Journal of Robotic Surgery. PMID 31520275 DOI: 10.1007/S11701-019-01025-X |
0.322 |
|
| 2018 |
Ni Z, Kim SJ, Phielipp N, Ghosh S, Udupa K, Gunraj CA, Saha U, Hodaie M, Kalia SK, Lozano AM, Lee DJ, Moro E, Fasano A, Hallett M, Lang AE, et al. Pallidal deep brain stimulation modulates cortical excitability and plasticity. Annals of Neurology. PMID 29369401 DOI: 10.1002/Ana.25156 |
0.332 |
|
| 2015 |
Mestre TA, Beaulieu-Boire I, Aquino CC, Phielipp N, Poon YY, Lui JP, So J, Fox SH. What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease? Parkinsonism & Related Disorders. 21: 1349-54. PMID 26439944 DOI: 10.1016/J.Parkreldis.2015.09.044 |
0.333 |
|
| 2014 |
Espay AJ, Edwards MJ, Oggioni GD, Phielipp N, Cox B, Gonzalez-Usigli H, Pecina C, Heldman DA, Mishra J, Lang AE. Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor. Parkinsonism & Related Disorders. 20: 647-50. PMID 24679736 DOI: 10.1016/J.Parkreldis.2014.02.029 |
0.303 |
|
| 2012 |
Elahi B, Phielipp N, Chen R. N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 465-72. PMID 22728853 DOI: 10.1017/S0317167100013974 |
0.334 |
|
| Show low-probability matches. |